期刊文献+

^(18)F-FDG PET/CT在查找骨转移瘤原发灶中的价值 被引量:2

Value of ^(18)F-FDG PET/CT in detecting primary tumor in patients with bone metastases
下载PDF
导出
摘要 目的探讨18F-FDG PET/CT在查找骨转移瘤原发灶中的应用价值及不同类型骨转移瘤的PET/CT特点。方法回顾性分析34例原发灶不明的骨转移瘤患者病例资料,经常规检查未发现原发灶,行18F-FDG PET/CT扫描查找原发灶。比较溶骨性转移瘤和成骨性转移瘤SUVmax的差异。结果经组织细胞学或3个月以上的临床随访证实,34例患者中,PET/CT检出22例原发灶(64.71%)。12例PET/CT未发现原发灶(35.29%)。23例溶骨性为主转移瘤和11例成骨性为主转移瘤的SUVmax分别为6.78±3.66和4.13±1.69(P<0.05)。结论18F-FDG PET/CT显像可提示多数骨转移瘤患者的原发灶,进而指导患者的治疗计划。溶骨性转移瘤的代谢活性较成骨性转移瘤更高。 Objective To assess the value of 18F-FDG PET/CT in detecting primary tumors of patients with bone metastases,and to observe PET/CT characteristics of different types of bone metastases.Methods Whole-body 18F-FDG PET/CT images of 34 patients with metastatic bone from unknown primary tumor(CUP) were retrospectively analyzed,and SUVmax was compared in osteolytic and osteoblastic subgroups based on CT characteristics.Results Diagnosis of these patients were confirmed by histopathological findings or ≥3 months follow-up.Primary tumors were detected with PET/CT in 22 patients(64.71%).SUVmax was 6.78±3.66 in 23 osteolytic metastases,and 4.13±1.69 in 11 osteoblastic metastases(P〈0.05).Conclusion 18F-FDG PET/CT is helpful to find the localization of unknown primary tumors in patients with bone metastases,and to make treatment Planning.Osteolytic metastases show higher metabolic activity on 18F-FDG PET/CT.
出处 《中国医学影像技术》 CSCD 北大核心 2009年第12期2275-2278,共4页 Chinese Journal of Medical Imaging Technology
关键词 骨肿瘤 体层摄影术 发射型计算机 体层摄影术 X线计算机 18F氟脱氧葡萄糖 Bone neoplasms Tomography emission computed Tomography X-ray computed Fluorodeoxyglucose F18
  • 相关文献

参考文献11

二级参考文献47

  • 1侯庆仪,唐安戊,张祥松,陈丹.^(18)F-FDG PET显像对原发灶不明颈部淋巴结转移癌的诊断价值[J].中华核医学杂志,2004,24(3):167-167. 被引量:12
  • 2党亚萍,刘刚,王红,李苗.PET/CT对肺内结节诊断及治疗的临床价值[J].中华肿瘤杂志,2004,26(11):685-687. 被引量:21
  • 3赵春雷,高硕,陈秋松,李亚军,李大成,邢喜玲,王俊起.^(18)F-FDG PET/CT显像在非小细胞肺癌术前分期中的价值[J].中华核医学杂志,2005,25(2):78-81. 被引量:15
  • 4李景学 孙鼎元.骨关节X线诊断学[M].北京:人民卫生出版社,1998.372. 被引量:12
  • 5Castillo M,Arbelaez A,Smith JK,et al.Diffusion-weighted MR imaging offers no advantage over routine noncontrast MR imaging in the detection of vertebral metastases[J].AJNR,2000,21(5):948-953. 被引量:1
  • 6Chen WT,Shih TT,Chen RC,et al.Blood perfusion of vertebral lesions evaluated with gadolinium-enhanced dynamic MRI:in comparison with compression fracture and metastasis[J].J Magn Reson Imaging,2002,15(3):308-314. 被引量:1
  • 7Ryan PJ,Fogelman I.The bone scan:where are we now[J]? Semin Nucl Med,1995,25(2):76-91. 被引量:1
  • 8Peterson JJ,Kransdorf MJ,O'Connor MI.Diagnosis of occult bone metastases:positron emission tomography[J].Clin Orthop,2003,415(10):120-128. 被引量:1
  • 9Cook GJ,Houston S,Rubens R,et al.Detection of bone metastases in breast cancer by 18-FDG PET:Differing metabolic activity in osterblastic and osteolytic lesions[J].J Clin Oncol,1998,16(10):3375-3379. 被引量:1
  • 10Bury T,Barreto A,Daenen F,et al.Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer[J].Eur J Nucl Med,1998,25(9):1244-1247. 被引量:1

共引文献55

同被引文献20

  • 1王欣璐,王全师,吴湖炳,王巧愚,李洪生.应用全身^(18)F-FDG PET/PET-CT为脑转移瘤患者寻找原发灶[J].实用放射学杂志,2006,22(9):1130-1133. 被引量:7
  • 2邱贵华.^(18)F-FDG PET/CT在原发灶不明的淋巴结转移癌中的应用[J].第四军医大学学报,2007,28(13):1193-1195. 被引量:5
  • 3Gholam C, Grigoriadou S, Gilmour KC, et al. Familial haemophago- eytie lymphohistioeytosis: Advances in the genetic basis, diagnosis and management, Clin Exp Immunol, 2011,163(3) :271-283. 被引量:1
  • 4Janka GE. Familial and acquired hemophagoeytic lymphohistiocy- tosis. Eur J pediatr, 2007,166(2) :95-109. 被引量:1
  • 5Henter J, Samuelsson-Horne A, Arico M, et al. Treatment of he- mophagoeytic lymphohistioeytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood, 2002,100(7):2367-2373. 被引量:1
  • 6Celkan T, Berrak S, Kazanei E, et al. Malignancy-associated he-mophagocytic lymphohistiocytosis in pediatric cases: A multi- center study from Turkey. Turk J Pediatr, 2009,51 (3) : 207-213. 被引量:1
  • 7Gupta AA, Tyrrell P, Valani R, et al. Experience with hemoph- agocytic lymphohistiocytosis/macrophage activation syndrome at a single institution. Pediatr Hematol Oncol, 2009,31(2):81-84. 被引量:1
  • 8Han AR, Lee HR, Park BB, et al. Lymphoma-assoeiated he- mophagocytic syndrome: Clinical features and treatment out- come. Ann Hematol, 2007,86(7) :493-498. 被引量:1
  • 9Tong H, Ren Y, Liu H, et al. Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: Compari- son of T-cell lymphoma with and without hemophagocytic syn- drome. Leuk Lymphoma, 2008,49(1) :81-87. 被引量:1
  • 10Corapcioqlu F, Oneel S, Berberoqu K, et al. False positivity of FDG-PET during hemophagoeytie lymphohistioeytosis in child with Hodgkin lymphoma in remission. J Pediatr Hematol Oneol, 2009,31 ( 1 ) : 74-75. 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部